The Drug Enforcement Administration has asked the Justice Department’s inspector general to investigate allegations that federal agents knowingly allowed large quantities of fentanyl to reach New Mexico communities while attempting to build larger criminal cases against trafficking organizations. The request follows an Associated Press investigation that found DEA agents repeatedly monitored, but did not seize, major fentanyl shipments between 2023 and 2025.

According to one internal report, a 2023 operation in which agents watched a delivery of 74,000 counterfeit fentanyl pills at a mobile home park in Albuquerque without intervening. Current and former DEA agents told the outlet the tactic, known as letting drugs ‘walk,’ placed public safety at risk in a state already devastated by the fentanyl epidemic. Whistleblower and former DEA agent David Howell said he repeatedly warned supervisors that the strategy ‘poisoned our community to make cases.’

The allegations have sparked multiple investigations. New Mexico Gov. Michelle Lujan Grisham has asked the state’s attorney general to examine whether the DEA violated state law, while Democratic members of Congress are demanding answers about the agency’s tactics. DEA Administrator Terry Cole said the independent review is intended to examine the agency’s operational decisions and determine whether improvements are needed.

The controversy raises difficult questions about how far law enforcement should go when trying to dismantle large criminal organizations. Investigators often allow illegal activity to continue temporarily to identify higher-level traffickers, suppliers, and distribution networks that would otherwise remain hidden…

Beyond EarnPhone 2, Mode is expanding EarnOS licensing to OEM and carrier partners, enabling them to launch and power their own EarnOS-enabled devices while embedding income infrastructure directly into billions of smartphones at global scale.*

Invest now at $0.52/share

But the allegations in New Mexico have fueled rhetoric over the severity of the case and where the line should be drawn when the drugs in question are fentanyl, a drug responsible for tens of thousands of overdose deaths each year.

The investigation could also lead to changes in how future narcotics operations are conducted. If investigators conclude that existing policies were ignored or that oversight was insufficient, the DEA could face new restrictions on undercover tactics and tighter supervisory requirements.

Investigators will now have to answer a fundamental question: at what point does gathering more evidence stop justifying the decision to let deadly drugs continue moving through a community?

Fentanyl has already devastated communities across New Mexico and the U.S., leaving families and local health systems dealing with an overdose crisis that shows little sign of disappearing. Allegations that federal agents knowingly allowed shipments to continue moving through those same communities are likely to deepen public skepticism toward institutions that many Americans already believe have lost credibility.

If investigators conclude that existing safeguards failed, federal agencies are likely to face stricter oversight and greater public scrutiny whenever they conduct high-risk narcotics investigations. At a time when fentanyl remains one of the country’s deadliest drugs, the findings will help determine not only how future cases are built, but also how much trust Americans are willing to place in the agencies responsible for keeping their communities safe.

*Disclaimers: Please read the offering circular and related risks at invest.modemobile.com. This is a paid advertisement for Mode Mobile’s Regulation A+ Offering.

Mode Mobile recently received their ticker reservation with Nasdaq ($MODE), indicating an intent to IPO in the next 24 months. An intent to IPO is no guarantee that an actual IPO will occur.